Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01280409 · ClinicalTrials.gov registry record · Phase 4
Metformin Postpartum for GDM RCT for Reduced Weight Retention
A Phase 4 study of Diabetes, Gestational, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 114
- Enrollment target
- 2
- Study locations
NCT01280409 is a Phase 4 study of Diabetes, Gestational that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 114 participants, below the 450-participant average among 5 other Diabetes, Gestational trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT01280409, a Phase 4 study of Diabetes, Gestational, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 114 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine whether the study drug metformin is helpful in reducing weight after pregnancy in women with gestational diabetes. This pilot study will provide information on how well women are able to take metformin postpartum, whether metformin increases weight loss, and whether there are any increased risks of side effects to you as a new mother.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Metformin
Study Locations (2)
Texas
- Memorial Hermann Hospital, Texas Medical Center - Houston
- University of Texas Health Science Center at Houston, Professional Building - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2011-01 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01280409
The ClinicalTrials.gov registry entry for NCT01280409 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 450-participant average among 5 other Diabetes, Gestational trials with a reported enrollment target (75% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes, Gestational appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01280409 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01280409 about?
NCT01280409 is a clinical study titled "Metformin Postpartum for GDM RCT for Reduced Weight Retention". The purpose of this study is to determine whether the study drug metformin is helpful in reducing weight after pregnancy in women with gestational diabetes. This pilot study will provide information on how well women are able to take metformin postpartum, whether metformin increases weight loss, and...
What is the current status of trial NCT01280409?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 114 participants. The study started on 2011-01. Estimated completion is 2014-08.
What conditions does trial NCT01280409 study?
This clinical trial studies the following conditions: Diabetes, Gestational.
What interventions are being tested in trial NCT01280409?
The interventions under investigation include: Placebo (DRUG), Metformin (DRUG).
Who is sponsoring clinical trial NCT01280409?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01280409 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes, Gestational
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes
RECRUITING · Phase 2
-
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
ACTIVE NOT RECRUITING · Phase 2
-
Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
COMPLETED
-
Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes
COMPLETED · NA
-
Metabolism, Breastmilk, and Microbiome
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.